drugset / Trial / NCT03901937

The Effects of Parenteral ω-3 Polyunsaturated Fatty Acid on Postoperative Complications of Patients With Crohn's Disease

NCT03901937 ↗

Phase 4 Unknown 158 enrolled Sir Run Run Shaw Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study is intended to investigate the safety and efficacy of ω-3 polyunsaturated fatty acid-based parenteral nutrition (PN) for patients with Crohn's disease.

Timeline

Start
2019-03-01
Primary completion
2020-09-01
Completion
2021-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator ω-3 polyunsaturated fatty acid Unknown 0.1 g/kg Other
Comparator ω-3 polyunsaturated fatty acid Unknown 0.2 g/kg Other

Indications